Nanoly Bioscience Overview
- Year Founded
-
2012
- Status
-
Out of Business
- Employees
-
4
- Latest Deal Type
-
Out of Business
Nanoly Bioscience General Information
Description
Developer of a biocompatible polymer technology designed to stabilize temperature-sensitive protein molecules during storage, transport, and use. The company's technology offers a revolutionary type of additive that can extend the temperature-controlled shelf life of unstable molecules and also completely eliminate the need for temperature-controlled storage for some, enabling clients to eliminate refrigeration for vaccines and protein therapeutics.
Contact Information
Website
www.nanoly.infoCorporate Office
- 9066 East Colorado Circle
- Denver, CO 80231
- United States
Corporate Office
- 9066 East Colorado Circle
- Denver, CO 80231
- United States
Nanoly Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Out of Business | 01-Dec-2023 | Completed | Out of Business | |||
| 6. Accelerator/Incubator | 01-Jan-2017 | Completed | Generating Revenue | |||
| 5. Seed Round | 10-May-2016 | Completed | Generating Revenue | |||
| 4. Grant | 14-Feb-2016 | Completed | Generating Revenue | |||
| 3. Grant | 13-Nov-2014 | Completed | Generating Revenue | |||
| 2. Grant | 17-Sep-2014 | $75K | Completed | Generating Revenue | ||
| 1. Grant | 01-Jan-2013 | $65K | Completed | Generating Revenue |
Nanoly Bioscience Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
Nanoly Bioscience Comparisons
Industry
Financing
Details
Nanoly Bioscience Competitors (1)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Vaxess Technologies | Venture Capital-Backed | Cambridge, MA |
Nanoly Bioscience Patents
Nanoly Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220142919-A1 | Dynamic covalently linked hydrogels as stabilization network platforms | Inactive | 06-Mar-2019 | ||
| EP-3463485-A1 | Photolabile compositions as a stabilization platform | Inactive | 31-May-2016 | ||
| US-20190091346-A1 | Photolabile compositions as a stabilization platform | Inactive | 31-May-2016 | ||
| EP-3463485-A4 | Photolabile compositions as a stabilization platform | Inactive | 31-May-2016 | A61K47/6903 |
Nanoly Bioscience Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Nanoly Bioscience FAQs
-
When was Nanoly Bioscience founded?
Nanoly Bioscience was founded in 2012.
-
Who is the founder of Nanoly Bioscience?
Balaji Sridhar Ph.D, Mark Tibbitt Ph.D, Peter Matheu Ph.D, Ting-Ting Zhou, and Nanxi Liu are the founders of Nanoly Bioscience.
-
Where is Nanoly Bioscience headquartered?
Nanoly Bioscience is headquartered in Denver, CO.
-
What is the size of Nanoly Bioscience?
Nanoly Bioscience has 4 total employees.
-
What industry is Nanoly Bioscience in?
Nanoly Bioscience’s primary industry is Biotechnology.
-
Is Nanoly Bioscience a private or public company?
Nanoly Bioscience is a Private company.
-
What is Nanoly Bioscience’s current revenue?
The current revenue for Nanoly Bioscience is .
-
How much funding has Nanoly Bioscience raised over time?
Nanoly Bioscience has raised $1.08M.
-
Who are Nanoly Bioscience’s competitors?
Vaxess Technologies is a competitor of Nanoly Bioscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
